Treatment of bone disease in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 6, 2004, Pages 524-530

  Aris, Robert ^a,b   Lester, Gayle ^b,c   Ontjes, David ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Bisphosphonates; Bone density; Bone disease; Cystic fibrosis; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM 45; COLECALCIFEROL; CORTICOSTEROID; ERGOCALCIFEROL; ETIDRONIC ACID; GLUCOCORTICOID; HORMONE; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PREDNISONE; RECOMBINANT GROWTH HORMONE; SEX HORMONE; STATIN; TESTOSTERONE; TESTOSTERONE ENANTATE; VITAMIN D; VITAMIN K GROUP;

BODY MASS; BONE DENSITY; BONE DISEASE; BONE MASS; BONE MINERAL; BONE PAIN; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DELAYED PUBERTY; DISEASE ASSOCIATION; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEVER; FORCED EXPIRATORY VOLUME; FRACTURE; GROWTH RETARDATION; HUMAN; HYPOGONADISM; LUNG TRANSPLANTATION; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHLEBITIS; REVIEW; SCREENING; THORAX RADIOGRAPHY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 7444255989     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcp.0000142923.00683.d2     Document Type: Review

References (69)

1. Cystic Fibrosis Foundation: Patient Registry 2002 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation; 2003.
2. Cystic Fibrosis Foundation Consensus Conferences: Concepts in Care: Guide to Bone Health and Disease in Cystic Fibrosis, Vol. X, Sec. 4, June 2002. Bethesda, MD. This is a complete overview of the incidence, pathogenesis, clinical manifestations, diagnosis, and treatment of bone disease in children and adults with cystic fibrosis.
3. Elkin SL, Vedi S, Bord S, et al.: Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 2002, 166:1470-1474. This paper is the first description of the static and dynamic measurements of bone histomorphometry in adults with CF. It provides critical insights into the pathogenesis of CF bone disease.
4. Haworth CS, Webb AK, Egan JJ, et al.: Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000, 118:434-439.
5. De Schepper J, Smitz J, Dab I, et al.: Low serum bone gamma-carboxyglutamic acid protein concentrations in patients with cystic fibrosis: correlation with hormonal parameters and bone mineral density. Horm Res 1993, 39:197-201.
6. Baroncelli GI, De Luca F, Magazzu G, et al.: Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 1997, 41:397-403.
7. Aris RM, Stevens A, Ontjes DA, et al.: Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000, 162:1674-1678.
8. Aris RM, Ontjes DA, Buell HE, et al.: Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 2002, 13:151-157.
9. Mischler EH, Chesney PJ, Chesney RW, Mazess RB: Demineralization in cystic fibrosis detected by direct photon absorptiometry. Am J Dis Child 1979, 133:632-635.
10. Hahn TJ, et al.: Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr 1979, 94:38-42.
11. Erkkila J, Warwick W, Bradford D: Spine deformities and cystic fibrosis. Clin Orthop 1978, 131:146-149.
12. Denton J, Tietjen R, Gaerlan P: Thoracic kyphosis in cystic fibrosis. Clin Orthop 1979, 155:71-74.
13. Logvinoff M, Fon G, Taussig LM, et al.: Kyphosis and pulmonary function cystic fibrosis. Clin Pediatr 1984, 23:389-392.
14. Gibbens DT, et al.: Osteoporosis in cystic fibrosis. J Pediatr 1988, 113:295-300.
15. Grey AB, Ames RW, Matthews RD, et al.: Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993, 48:589-593.
16. Bachrach LK, Loutit CW, Moss RB: Osteopenia in adults with cystic fibrosis. Am J Med 1994, 96:27-34.
17. Rochat T, Slosman DO, Pichard C, et al.: Body composition analysis by dual-energy x-ray absorptiometry in adults with cystic fibrosis. Chest 1994, 106:800-805.
18. Henderson RC, Specter BB: Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 1994, 125:208-212.
19. Shaw N, Bedford C, Heaf D, et al.: Osteopenia in adults with cystic fibrosis. Am J Med 1995, 99:690-692.
20. Henderson RC, Madsen CD: Bone density in children and adolescents with cystic fibrosis. J Pediatr 1996, 128:28-34.
21. Bhudhikanok GS, Lim J, Marcus R, et al.: Correlates of Osteopenia in patients with cystic fibrosis. Pediatrics 1996, 97:103-111.
22. Aris RM, Neuringer IP, Egan TM, et al.: Severe osteoporosis before and after lung transplantation. Chest 1996, 109:1176-1183.
23. Shane E, Silverberg SJ, Donovan D, et al.: Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996, 101:262-269.
24. Salamoni F, Roulet M, Gudinchet F, et al.: Bone mineral content in cystic fibrosis patients: correlation with fat-free mass. Arch Dis Child 1996, 74:314-318.
25. Bhudhikanok GS, Wang MC, Marcus R, et al.: Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 1998, 133:18-27.
26. Humphries IR, Alien JR, Waters DL, et al.: Volumetric bone mineral density in children with cystic fibrosis. Appl Radiat Isot 1998, 49:593-595.
27. Aris RM, Renner JB, Winders AD, et al.: Increased rate of fractures and severe kyphosis: sequelae of living to adulthood with cystic fibrosis. Ann Intern Med 1998, 128:186-193.
28. Henderson RC, Madsen CD: Bone mineral content and body composition in children and young adults with cystic fibrosis. Pediatr Pulmonol 1999, 27:80-84.
29. Haworth CS, Selby PL, Webb AK, et al.: Low bone mineral density in adults with cystic fibrosis. Thorax 1999, 54:961-967.
30. Moran CE, Sosa EG, Martinez SM, et al.: Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 1997, 92:867-871.
31. Laursen EM, Molgaard C, Michaelsen KF, et al.: Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 1999, 81:235-240.
32. Conway SP, Morton AM, Oldroyd B, et al.: Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000, 55:798-804.
33. Hardin DS, Arumugam R, Seilheimer DK, et al.: Normal bone mineral density in cystic fibrosis. Arch Dis Child 2001, 84:363-368.
34. Sood M, Hambleton G, Super M, et al.: Bone status in cystic fibrosis. Arch Dis Child 2001, 84:516-520.
35. Donovan DS Jr, Papadopoulos A, Staron RB, et al.: Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease. Am J Respir Crit Care Med 1998, 157:1892-1899.
36. Mortensen LA, Chan GM, Alder SC, et al.: Bone mineral status in prepubertal children with cystic fibrosis. J Pediatr 2000, 136:648-652.
37. Elkin SL, Fairney A, Burnett S, et al.: Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001, 12:366-372.
38. Buntain HM, Greer RM, Schluter PJ, et al.: Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004, 59:149-155. This is the most up-to-date cross-sectional study of a large cohort of CF adults and children demonstrating that prepubertal children with CF who are well nourished have normal bone density (in comparison to healthy controls), but that deficits in bone density were noted in adolescents and these deficits worsened in adults with CF. These data are consistent with the general paradigm that CF bone disease finds its beginning in late childhood or early puberty. In addition, individuals with CF had similar levels of vitamin D while lower bone density and higher bone turnover, suggesting that vitamin D repletion may not have a large impact on bone density in CF.
39. Gronowitz E, Garemo M, Lindblad A, et al.: Decreased bone mineral density in normal-growing patients with cystic fibrosis. Acta Paediatr 2003, 92:688-693. This is a cross-sectional study of 70 children and adults in Sweden that indicated that children with CF have lower bone density than healthy controls despite normal anthropometry, and bone density declines into adulthood.
40. Brenckmann C, Papaioannou A, Freitag A, et al.: Osteoporosis in Canadian adult cystic fibrosis patients: A descriptive study. BMC Musculoskelet Disord 2003, 4:13.
41. Haworth CS, Selby PL, Horrocks AW, et al.: A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 2002, 57:719-723. Excellent, large longitudinal study in CF adults that demonstrates accelerated annual bone losses at the femoral neck and total hip (∼2%/year), but not at the spine and distal forearm.
42. Aris RM, Lester GE, Camaniti M, et al.: Efficacy of alendronate in cystic fibrosis adults with low bone density. Am J Respir Crit Care Med 2004, 169:77-82. This randomized controlled trial demonstrates the safety and efficacy of oral alendronate for improving bone density in adults with CF who have low bone density.
43. Ujhelyi R, Treszl A, Vasarhelyi B, et al.: Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: a follow-up study. J Pediatr Gastroenterol Nutr 2004, 38:401-406.
44. Tschopp O, Boehler A, Speich R, et al.: Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2002, 2:167-172.
45. Hecker TM, Aris RM: Management of osteoporosis in adults with cystic fibrosis. Drugs 2004, 64:133-147. This review article focuses on the pathogenesis, diagnosis and management of adults with CF and low bone density.
46. Ott SM, Aitken ML: Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998, 19:555-567.
47. Lark RK, Lester GE, Ontjes DA, et al.: Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 2001, 73:602-606.
48. Hanly JG, McKenna MJ, Quigley C, et al.: Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 1985, 56:377-385.
49. Kelly E, Marsh R, Pencharz P, et al.: Effect of vitamin D supplementation on low serum 25-hydroxyvitamin D in adults with cystic fibrosis [abstract]. Pediatr Pulmonol 2002, Suppl 24:344.
50. Boyle MP, Noschese ML, Watts SL, et al.: Prevalence of 25-hydroxyvitamin D deficiency in adults with CF and effect of high dose ergocalciferol supplementation [abstract]. Ped Pulmonol 2003, suppl 25:350.
51. Enfissi L, Bianchi ML, Galbiati E, et al. Osteoporosis in CF: Calcifediol therapy increases bone mineral density (BMD). Pediatric Pulm 2001, Suppl 22:334.
52. 2D) treatment in improving measures of calcium homeostasis without causing adverse effects.
53. Barger-Lux MJ, Heaney RP, Dowell S, et al.: Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998, 8:222-230.
54. Vieth R, Chan PC, MacFarlane GD: Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001, 73:288-294.
55. Hypponen E, Laara E, Reunanen A, et al.: Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
56. Ontjes DA, Lark RK, Lester GE, et al.: Vitamin D depletion and replacement in patients with cystic fibrosis. In Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects. Edited by Norman A, Bouillon R, Thomasset. University of California, Riverside, 2000:893-896.
57. Wilson DC, Rashid M, Durie PR, et al.: Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination. J Pediatr 2001, 138:851-855.
58. Aris RM, Brown SA, Ontjes DA, et al.: Reduced carboxylated osteocalcin levels in cystic fibrosis. Am J Respir Crit Care Med 2003, 168:1129. Cross-sectional study showing that adults with CF have lower levels of carboxylated osteocalcin than health controls and that this abnormality may contribute to bone disease.
59. van Hoorn JH, Hendriks JJ, Vermeer C, et al.: Vitamin K supplementation in cystic fibrosis. Arch Dis Child 2003, 88:974-975. Short-term study demonstrating that vitamin K improved the carboxylation of osteocalcin, and thus may be of value in improving bone health in CF.
60. Leifke E, Friemert M, Heilmann M, et al.: Sex steroids and body composition in men with cystic fibrosis. Eur J Endocrinol 2003, 148:551-557.
61. Stead RJ, Hudson ME, Batten JC, et al.: Amenorrhoea in cystic fibrosis. Clin Endocrinol (Oxf) 1987, 26:187-195.
62. Landon C, Rosenfeld RG: Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment. Am J Dis Child 1984, 138:388-391.
63. Haworth CS, Selby PL, Adams JE, et al.: Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001, 56:314-316.
64. Haworth CS, Selby PL, Webb AK, et al.: Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis. Lancet 1998, 352:1753-1754.
65. Haworth CS, Selby PL, Webb AK, et al.: Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis. Lancet 1999, 353:1886.
66. Aris RM, Lester GE, Renner JB, et al.: Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000, 162:941-946.
67. de Groen PC, Lubbe DF, Hirsch LJ, et al.: Esophagitis associated with the use of alendronate. N Eng J Med 1996, 335:1016-1021.
68. Hardin DS, Ellis KJ, Dyson M, et al.: Growth hormone decreases protein catabolism in children with cystic fibrosis. J Clin Endocrinol Metab 2001, 86:4424-4428.
69. Hardin DS, Ellis KJ, Dyson M, et al.: Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial. J Pediatr 2001, 139:636-642.